Pegfilgrastim

Last updated 28 Mar 2025 | 06:20 AM (UTC)

Pegfilgrastim Uses

Pegfilgrastim is used to prevent infections after chemotherapy.

How Pegfilgrastim works

Pegfilgrastim is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections. .

Common side effects of Pegfilgrastim

Joint pain, Headache, Muscle pain, Back pain, Injection site pain, Hair loss, Fever, Diarrhea, Skeletal pain, Limb pain, Musculoskeletal (bone, muscle or joint) pain, Neck pain

Want to Know More

Read Our Editorial Policy

Medicine brands for Pegfilgrastim

Dr Reddy's Laboratories Ltd

₹3414 to ₹3414

2 variant(s)

Pegasta

Intas Pharmaceuticals Ltd

Biochem Pharmaceutical Industries

₹3206 to ₹3206

1 variant(s)

Pegex

Emcure Pharmaceuticals Ltd

₹3300 to ₹3300

1 variant(s)

Pegg Trust

Panacea Biotec Pharma Ltd

Zuventus Healthcare Ltd

₹6000 to ₹6000

1 variant(s)

Expert advice for Pegfilgrastim

Pegfilgrastim reduces the risk of infection in people treated with chemotherapy.
It is usually given as a daily injection into the tissue just under the skin or into the vein.
You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
Store it in the refrigerator, protect it from light, and don't shake it.
For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
Use caution while driving or doing anything that requires concentration as Pegfilgrastim may cause dizziness.
Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
Stop taking Pegfilgrastim and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
Pegfilgrastim reduces the risk of infection in people treated with chemotherapy.
It is usually given as a daily injection into the tissue just under the skin or into the vein.
You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
Store it in the refrigerator, protect it from light, and don't shake it.
For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
Use caution while driving or doing anything that requires concentration as Pegfilgrastim may cause dizziness.
Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
Stop taking Pegfilgrastim and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.

Frequently asked questions for Pegfilgrastim

Q. What is Pegfilgrastim? How is it given?

Pegfilgrastim belongs to a class of medications called colony stimulating factors. It helps reduce the chances of infections and side effects related to chemotherapy and does not directly treat cancer. It comes as a solution (liquid) to inject subcutaneously (under the skin), 24 hours after chemotherapy. It may be injected by a doctor/nurse in a hospital or you may be shown how to use injections at home

Q. How does pegfilgrastim work?

Pegfilgrastim belongs to a class of medications called colony stimulating factors. It acts on hematopoietic cells (cells in the bone marrow that produce red blood cells, white blood cells, and platelets) to increase production of neutrophils (a type of white blood cell) in the body.